Sign in Register

Aggrastat In Sodium Chloride (tirofiban HCl monohydrate in 0.9 % sodium chloride)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Generic name: tirofiban HCl monohydrate in 0.9 % sodium chloride

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Aggrastat In Sodium Chloride

Intelligence content is not available yet.

Indications

The following indications are listed for Aggrastat In Sodium Chloride:

  • Acute Coronary Syndrome
  • Non Q-Wave Myocardial Infarction
  • Percutaneous Coronary Intervention Adjunct For Thrombosis Prevention
  • Unstable Angina Pectoris

Also known as: Crescendo Angina, Non-Q Wave Myocardial Infarction, Preinfarction Syndrome, Unstable Angina.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data